112742-09-3

Basic information

• Product Name: 3,4-dimethoxy-2',4'-bis-methoxymethoxy-trans-chalcone
• CAS NO: 112742-09-3
• Molecular Weight: 388.417
• Mol File: 112742-09-3.mol

Chemical Properties

• CAS DataBase Reference: 3,4-dimethoxy-2',4'-bis-methoxymethoxy-trans-chalcone(CAS DataBase Reference)
• NIST Chemistry Reference: 3,4-dimethoxy-2',4'-bis-methoxymethoxy-trans-chalcone(112742-09-3)
• EPA Substance Registry System: 3,4-dimethoxy-2',4'-bis-methoxymethoxy-trans-chalcone(112742-09-3)

Safety Data

• Hazardous Substances Data: 112742-09-3(Hazardous Substances Data)

Upstream product

• 89-84-9 2',4'-dihydroxy-4-acetophenone 
• 6515-05-5 2',4'-bis(methoxymethoxy)acetophenone 
• 120-14-9 3,4-dimethoxy-benzaldehyde 

Downstream Products

• 104236-80-8 (E)-1-(2,4-dihydroxyphenyl)-3-(3,4-dimethoxyphenyl)prop-2-en-1-one 

Relevant articles and documents

Synthesis and biological evaluation of isoliquiritigenin derivatives as a neuroprotective agent against glutamate mediated neurotoxicity in HT22 cells

Glutamate-induced neurotoxicity is characterized by cellular Ca2+ uptake, which is upstream of reactive oxygen species (ROS)-induced apoptosis signaling and MAPKs activation. In the present study, we synthesized isoliquiritigenin analogs with electron-donating and electron-withdrawing functional groups. These analogs were evaluated for neuroprotective effect against glutamate-induced neurotoxicity in HT22 cells. Among these analogs, compound BS11 was selected as a potent neuroprotective agent. Cellular Ca2+ concentration, ROS level, MAPKs activation and AIF translocation to the nucleus were increased upon treatment with 5 mM glutamate. In contrast, we identified that compound BS11 reduced the cellular Ca2+ concentration and ROS level upon glutamate exposure. Western blot analysis showed that MAPK activation was decreased by treatment with compound BS11. We further identified that cotreatment of compound BS11 and glutamate inhibited translocation of AIF to the nucleus.